User Clip: Albert Bourla (CEO, Pfizer) (Rebate Mention)
Albert Bourla (CEO, Pfizer) (Rebate Mention)
- 5 minutes
- 556 views
Albert Bourla (CEO, Pfizer) (Rebate Mention)
Richard Gonzalez, CEO, AbbVie (Rebate Mention)
New Jersey Democratic Senator Bob Menendez issues a "friendly warning" to the CEO's of several pharmaceutical companies testifying on Capitol Hill, telling them that the issue is a public…
Question involves whether companies set the "list price" of drugs, which determines how much patients pay at the pharmacy counter.
Kenneth Frazier (CEO, Merck) (Rebate Mention)
Jennifer Taubert, CEO, Johnson & Johnson
Pascal Soriot explains that the government must "change the rules" by reducing rebates.
Sen. John Cornyn suggests the Senate Judiciary Committee should look into how drugmakers manipulate the patent system to block competition.
Merck CEO Kenneth Frazier says he can’t cut prices due to the rebate trap. Sen. Steve Daines then asks the panel whether they are supportive of the CREATES Act.
Senator Johnny Isakson (R-GA) Questions CEOs about Factors Contributing to Drug Prices (Rebate Mention)
Sen. Wyden Questions Humira Exec Bonuses
Senator Cassidy questions PBM's ability to negotiate, as well as Medicare's ability to do so.
Sen. Sheldon Whitehouse (D-Rhode Island) talks about how off patent monopolies are used to impose monopoly pricing in the industry. All the CEOs seem to agree with him.
Pascal Soriot (CEO, AstraZeneca) (Rebate Mention)
Senator Steve Daines (R-MT) Questions CEOs on Who Pays List Price and Factors that Contribute to List Price (Rebate Mention)
Senator Grassley (R-IA) Questions CEOs on the Companies' Ability to Reform Policies (Rebate Mention)